ÂÜÀòÂÒÂ×

CSO and Member of the SAB. Dr. Arbeeny has extensive experience within the pharmaceutical, biotechnology and academic sectors. She has broad knowledge across all functional areas of biopharma R&D with expertise in metabolic diseases. Dr. Arbeeny has been involved in advancing several compounds from discovery and preclinical research to Phase I clinical trials. She is currently the President of BioNavigation Consulting LLC and provides consulting services to large and medium sized companies, biopharma startups and investment groups. Dr. Arbeeny was the Head of Strategic Opportunities, Diabetes Co-Morbidities and Complications and Vice President for Portfolio Strategy and External Innovation at Sanofi and was Vice President for Endocrine and Metabolic Disease Research at Genzyme. She worked as an independent consultant for the Biopharma industry, as a Research Investigator at Bristol Myers Squibb and as an Assistant Professor at The Albert Einstein College of Medicine. She received a BS in Biology with highest honors from Richmond College and a Ph.D in Physiology from Rutgers University.